C12Y 301/01068
Xylono-1,4-lactonase
Official title: Xylono-1,4-lactonase (3.1.1.68)
C12Y301/01068 (Xylono-1,4-lactonase) appears on 6 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 7
- Assignees
- 9
- Inventors
- 21
- Latest grant
- 2 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 1 | 2 |
| 2019 | 0 | 1 |
| 2020 | 2 | 2 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Modulation of carbon flux through the meg and C3 pathways for the improved production of monoethylene glycol and C3 compounds2 Dec 2025US 12,486,513 B2Braskem S/A
- Escherichia coli transformant for producing itaconate and uses thereof20 Apr 2021US 10,982,238 B2Chang Chun Petrochemical Co., Ltd.
- Modified microorganism for the optimized production of 2,4-dihydroxybutyrate with enhanced 2,4-dihydroxybutyrate efflux8 Dec 2020US 10,858,675 B2Metabolic Explorer
- Recombinant microorganism having ability to produce poly(lactate-coglycolate) or copolymer thereof from xylose and method for preparing poly(lactate-coglycolate) or copolymer thereof by using same5 May 2020US 10,640,774 B2Korea Advanced Institute of Science and Technology
- Biosynthetic pathways and methods6 Mar 2018US 9,909,129 B2Regents of the University of Minnesota
- Escherichia coli transformant for producing itaconate and uses thereof15 Oct 2020US 2020/0325503 A1Chang Chun Petrochemical Co., Ltd.
- Modulation of carbon flux through the meg and c3 pathways for the improved production of monoethylene glycol and c3 compounds2 Jul 2020US 2020/0208160 A1Braskem S/A
- Recombinant microorganism having ability to produce poly(lactate-coglycolate) or copolymer thereof from xylose and method for preparing poly(lactate-coglycolate) or copolymer thereof by using same24 Jan 2019US 2019/0024093 A1Korea Advanced Institute of Science and Technology
- A modified microorganism for the optimized production of 2,4-dihydroxybutyrate with enhanced 2,4-dihydroxybutyrate efflux19 Apr 2018US 2018/0105845 A1Metabolic Explorer
- Biosynthetic pathways and methods22 Mar 2018US 2018/0080032 A1Regents of the University of Minnesota
Most cited
By later US patents